Pioneering
First Clinically Recommended
Genome-Wide Pharmacogenomics
Actionable insights for safer therapies, personalised treatment, and better outcomes.
Trusted by leading institutions & healthcare partners
Precision diagnostics that scale
From pioneering clinical standards to real-world patient impact across Asia Pacific.
across therapeutic areas
by actionable insights
including oncology & cardio
for genome-wide PGx
DNA tests we currently provide
Clinically accredited, guideline-aligned reports designed for real clinical decision-making.
PRECISE Pharmacogenomics (PGx)
Genome-wide pharmacogenomic profiling covering 1,000+ genes and 500+ medications. Supports safer prescribing across oncology, cardiology, psychiatry, neurology, pain and more.
Learn more →
PRECISE Nutrigenomics (NGx)
Evidence-based, clinically actionable nutritional recommendations aligned with Medical Nutrition Therapy and recognised dietary guidelines.
Learn more →
PRECISE Onco⁺
Germline pharmacogenomic test for personalised and safer cancer care. Lifelong insights that complement tumour testing and guide therapy from the start.
Learn more →Our Board of Advisors
Distinguished clinicians, scientists and policymakers shaping the future of precision medicine in Asia Pacific.
